REVEAL GENOMICS, S.L. is a Barcelona-based biotechnology company that discovers, develops, and markets innovative diagnostic ...

Spanish cancer biomarker medtech Reveal Genomics has boosted the roles of three of its founding members. | Spanish cancer biomarker medtech Reveal Genomics has boosted the roles of three of its ...

Wellcome Sanger Institute Senior Group Leader, and former Institute Director, Professor Sir Mike Stratton has been awarded ...

Predictive genomics enhances breast cancer management by integrating predictive medicine, personal genomics, and translational bioinformatics for personalized care. Key applications include ...

AstraZeneca's Dr. Sophie Kirschner to present data demonstrating how biomodal's 6--base sequencing solution enhances the sensitivity of liquid biopsy ...

In 2022, NIST started the Cancer Genome in a Bottle program as part of a major partnership between government, universities and industry to focus on fighting cancer. Specifically, the goal of the ...

On April 13, 2023, the National Cancer Policy Forum of the National Academies of Sciences, Engineering, and Medicine will convene a virtual, public workshop to explore the state of the science with ...

The study of cancer genomics has revealed that both inherited (germline) and acquired (somatic) genetic variations significantly influence cancer ...

LA JOLLA, Calif., Dec. 17, 2025 (GLOBE NEWSWIRE) -- Singlera Genomics, a company focused on the application of novel DNA methylation technologies to genetic diagnosis, with their partner Breakthrough ...

Cancer genomics has revolutionised our understanding of tumour biology by deciphering the complex genetic alterations that underpin oncogenesis. Central to this field is the identification and ...